Solifenacin Award

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-25-D-0017

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Hauppauge, New York, UNITED STATES

SourceSAM
Documents2
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued an award notice for the procurement of Solifenacin, a pharmaceutical product. This notice, identified by procurement number SPE2D2-25-D-0017, pertains specifically to a contract modification that exercises option year one, thereby extending the period of performance for the awarded contract. The scope of this procurement centers on the manufacturing and supply of Solifenacin, a medication classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing, 2022 version) and product service code 6505, which covers drugs and biologicals. The place of performance is designated as Hauppauge, New York, ensuring that all manufacturing, delivery, and related activities occur within the United States. DLA Troop Support, a federal office within the Defense Logistics Agency, is the contracting entity responsible for overseeing this procurement. The agency’s primary objective is to secure a reliable supply of Solifenacin to meet the ongoing needs of its stakeholders, likely supporting military healthcare requirements. The modification to exercise the option year reflects the agency’s commitment to continuity and sustained supply, ensuring that the contract’s terms and deliverables remain consistent throughout the extended period. Key requirements for contractors include compliance with pharmaceutical manufacturing standards as outlined in the relevant NAICS and product service codes. The expected deliverables are the timely and consistent provision of Solifenacin, meeting all quality and regulatory specifications as required by federal procurement guidelines. The notice remains active as of the posting date, March 9, 2026, and is accessible via the SAM.gov portal (Opportunity ID: 9cee4277b78d4f4d9da34f7be343146a). Interested parties or current contractors may direct inquiries to the primary contact, Jayne Do ([email protected], (445) 737-5764), or the secondary contact, Jason Wray ([email protected], 445-737-6304). No information regarding set-aside requirements or special considerations is provided in this notice. Contractors evaluating this opportunity should focus on their capacity to manufacture and supply pharmaceutical preparations in accordance with federal standards and the specific needs of DLA Troop Support. The contract’s core elements—manufacturing, supply, and compliance—will remain constant throughout the lifecycle of the agreement.